AHNAK2 and breast carcinoma: To further investigate the predicted aggressive phenotypic alterations observed, we also investigated the expression of specific EMT marker, such as: AKT1, AHNAK2, MUC1 and MUC5B, which were upregulated in both breast cancer cell lines (relative protein abundance levels in Supplementary Tables S6 and S7).